A question has been raised about GLGC. This is a stock that I have a position in and would like to open a dialog about the future of this company and what it has(IMO)to offer the major drug companies.
Gene Logic is a genomics and bioinformatics company that in only two years of existence, has created a nice association with many of the major drug companies...American Home, Merck, Proctor and Gamble, SmithKline, Rhone-Poulenc, and Japan Tobacco(Hell of name for a drug company). This is just a partial list of the nine companies that they have contracts with at the current time.
What I think might be a unique feature of this company is the Data Logic division, based in Berkeley, CA. They develop and market advanced bioformatics software for managing and integrating genomic data.
I would welcome any input from others as to the merits of GLGC. I would suggest everyone read the recent interview given by Michael Brennan, CEO, to The Wall Street Transcript. I think this is available at the news section for GLGC, here on SI. |
